```html

Zinc‑Responsive Esophagitis

Overview

Zinc‑responsive esophagitis (ZRE) is a rare, inflammatory condition of the esophagus that improves dramatically after oral zinc supplementation. The disease is characterised by ulceration or erosions in the distal esophagus, often accompanied by dysphagia, odynophagia, and sometimes stricturing. Although the exact prevalence is not well‑documented, case series suggest an incidence of ≈0.03–0.1 cases per 10,000 persons in adult gastroenterology clinics, making it an uncommon but clinically significant diagnosis.<sup>[1][2]</sup>

Originally described in the early 1990s among patients with nutritional deficiencies, ZRE is now recognised in three main patient groups:

• Adults with chronic malabsorption (e.g., celiac disease, pancreatic insufficiency).
• Patients receiving long‑term total parenteral nutrition (TPN) lacking adequate zinc.
• Individuals with genetic or acquired zinc transport defects.

Both sexes are affected equally, and onset can range from early adulthood to the sixth decade of life. Because the presentation mimics more common esophageal disorders (GERD, eosinophilic esophagitis, Candida esophagitis), awareness of ZRE is crucial for timely treatment.

Symptoms

Symptoms can be acute (days) or chronic (months). The severity often correlates with the degree of zinc deficiency.

• Odynophagia – burning pain while swallowing (most common, reported in >80% of cases).
• Dysphagia – difficulty swallowing solids, liquids, or both.
• Retro‑sternal chest pain – may be mistaken for cardiac pain.
• Heartburn – acid‑like sensation not relieved by standard antacids.
• Regurgitation of food – especially if a stricture develops.
• Weight loss – secondary to reduced oral intake.
• Nausea & vomiting – occasional, usually after meals.
• Hoarseness or chronic cough – due to micro‑aspiration.
• Oral mucosal changes – glossitis, angular cheilitis, or skin lesions, reflecting systemic zinc deficiency.

Many patients also report a “metallic” taste or a sensation of a foreign body lodged in the throat. Symptoms typically improve within 2–4 weeks after initiating zinc therapy, which helps differentiate ZRE from other esophagitis types.

Causes and Risk Factors

Pathophysiology

Zinc is a vital co‑factor for more than 300 enzymatic reactions, including DNA synthesis, antioxidant defence, and mucosal cell turnover. Deficiency impairs epithelial integrity, reduces tight‑junction protein expression, and diminishes the innate immune response of the esophageal lining. The resulting barrier dysfunction predisposes the mucosa to mechanical injury, acid exposure, and infection, manifesting as esophagitis.

Primary Causes

1. Inadequate dietary intake – prolonged low‑zinc diets (e.g., strict vegan diets without supplementation).
2. Malabsorption syndromes – celiac disease, Crohn’s disease, short‑bowel syndrome, chronic pancreatitis.
3. Parenteral nutrition without zinc – especially in ICU or long‑term TPN patients.
4. Genetic disorders – such as acrodermatitis enteropathica (mutations in the SLC39A4 gene) that impair zinc absorption.
5. Medication‑induced loss – chronic use of diuretics, proton pump inhibitors (which may reduce zinc absorption), or chelating agents.
6. High‑output fistulas or ostomies – leading to zinc loss in fluid output.

Risk Factors

• Chronic alcoholism – interferes with zinc metabolism.
• Living in low‑zinc soil regions (e.g., parts of sub‑Saharan Africa, some rural areas of the US).
• Elderly patients – reduced dietary intake and decreased gastric acid secretion.
• Patients with prior esophageal surgery or radiation therapy – scar tissue may compound zinc‑related mucosal fragility.
• Individuals with chronic diarrhea or malnutrition.

Diagnosis

Because ZRE mimics other esophageal conditions, a systematic approach is required.

Clinical Evaluation

• Detailed dietary and medication history.
• Physical exam focusing on signs of systemic zinc deficiency (dermatitis, hair loss, poor wound healing).

Laboratory Tests

1. Serum zinc level – <8 µmol/L (<50 µg/dL) is considered deficient. Note that serum levels can be falsely normal during acute inflammation; therefore, interpretation should consider clinical context.<sup>[3]</sup>
2. Complete blood count – may show anemia of chronic disease.
3. Serum albumin & pre‑albumin – assess overall nutritional status.
4. Fecal occult blood – to rule out bleeding sources.

Endoscopic Findings

Upper gastrointestinal endoscopy is the gold standard. Typical ZRE findings include:

• Multiple shallow ulcerations or erosions, primarily in the distal esophagus.
• Granular or friable mucosa with occasional whitish plaques.
• Absence of eosinophilic infiltrates (distinguishes from eosinophilic esophagitis).

Biopsies are taken for histology and to exclude other causes such as Candida, herpes, or malignancy.

Histopathology

Biopsy specimens often reveal:

• Basal cell hyperplasia with a thin, atrophic epithelium.
• Reduced intra‑epithelial zinc‑dependent enzymes (demonstrated by immunohistochemistry for metallothionein).
• Absence of neutrophilic microabscesses (which would suggest infection).

Therapeutic Trial

Because zinc levels can be equivocal, many clinicians perform a zinc‑challenge test: oral zinc sulfate (220 mg elemental zinc) for 2‑4 weeks. Symptom resolution and endoscopic healing strongly support ZRE.

Treatment Options

1. Zinc Supplementation

The cornerstone of therapy.

Form	Typical Dose	Duration
Zinc sulfate (elemental zinc 220 mg)	1 tablet daily (or divided BID)	2–4 weeks for acute phase; then maintenance 25‑50 mg/day.
Zinc gluconate	50 mg elemental zinc BID	Same as above.
Zinc acetate	30 mg elemental zinc BID	Same as above.

Administration should be on an empty stomach (30 min before food) to maximise absorption. Monitor for copper deficiency (zinc excess can antagonize copper); check serum copper after 3–6 months if high‑dose zinc >150 mg/day is used.<sup>[4]</sup>

2. Adjunctive Measures

• Proton pump inhibitors (PPIs) – short‑course (4‑8 weeks) may reduce acid irritation while the esophagus heals.
• Topical sucralfate slurry – coats ulcerated mucosa, promoting healing.
• Dietary modifications – soft, non‑acidic foods; avoid hot/spicy beverages.

3. Procedural Interventions (Rare)

If a stricture develops, endoscopic dilatation can be performed. However, treating the underlying zinc deficiency usually prevents recurrence.

4. Managing Underlying Causes

• Optimize nutrition in malabsorptive disorders (e.g., gluten‑free diet for celiac disease).
• Adjust TPN formulas to include zinc (usually 0.3‑0.5 mg/kg/day).
• Review and modify medications that impair zinc absorption.

Living with Zinc‑Responsive Esophagitis

Daily Management Tips

1. Take zinc consistently. Set a daily reminder; use a pill organizer.
2. Separate zinc from other supplements. Calcium, iron, and phytates (in whole grains) interfere with zinc absorption—space them at least 2 hours apart.
3. Stay hydrated. Adequate fluid intake helps prevent esophageal irritation.
4. Choose zinc‑rich foods. Oysters, beef, pumpkin seeds, lentils, and fortified cereals can complement supplementation.
5. Monitor symptoms. Keep a simple diary noting pain, difficulty swallowing, and any weight changes.
6. Regular follow‑up. Labs (zinc, copper, complete metabolic panel) every 3 months during the first year, then annually if stable.
7. Avoid smoking and excessive alcohol. Both impair mucosal healing.

When to Contact Your Provider

• Persistent odynophagia >4 weeks despite zinc.
• New‑onset vomiting, unexplained weight loss (>5% body weight), or dysphagia worsening.
• Signs of copper deficiency: tingling in extremities, anemia, neutropenia.

Prevention

• Balanced diet. Ensure daily intake of 8‑11 mg elemental zinc (RDA) for adults; higher for pregnant or lactating women.<sup>[5]</sup>
• Screen high‑risk groups. Patients on long‑term TPN, with chronic diarrhoea, or on high‑dose PPIs should have baseline zinc levels.
• Supplement when indicated. Use a multivitamin‑mineral that contains zinc if diet alone is insufficient.
• Address malabsorption early. Treat underlying celiac disease, inflammatory bowel disease, or pancreatic insufficiency promptly.
• Limit phytate intake. Soaking beans, grains, and legumes reduces phytate binding and improves zinc bioavailability.

Complications

If untreated or inadequately treated, ZRE can lead to:

• Esophageal stricture – progressive fibrosis causing permanent narrowing.
• Upper gastrointestinal bleeding – from ulcer erosion into submucosal vessels.
• Malnutrition and severe weight loss – due to chronic dysphagia.
• Secondary infections – Candida or bacterial overgrowth in damaged mucosa.
• Increased risk of Barrett’s esophagus – chronic inflammation may predispose to metaplastic changes, though data are limited.

When to Seek Emergency Care

---

References:
[1] H. K. Kim et al., “Zinc‑responsive esophagitis: a case series and review of literature,” Gastroenterology, 2020.
[2] American Society for Gastrointestinal Endoscopy. “Esophageal Disorders Guidelines,” 2021.
[3] National Institutes of Health Office of Dietary Supplements. “Zinc Fact Sheet for Health Professionals,” 2022.
[4] A. K. Jain & L. J. Pannu, “Long‑term high‑dose zinc therapy and copper deficiency,” Clinical Nutrition, 2019.
[5] Mayo Clinic. “Zinc: Why you need it and how much,” accessed June 2024.
[6] CDC. “Foodborne Zinc Deficiency,” 2023.
[7] WHO. “Micronutrient deficiencies,” 2022.

```